Determinants of salivary evening alpha-amylase in a large sample free of psychopathology

International Journal of Psychophysiology

Volumn 84, Issue 1, 2012, Pages 33-38

  Veen, Gerthe ^a,b   Giltay, Erik J ^b   Vreeburg, Sophie A ^a   Licht, Carmilla M M ^a   Cobbaert, Christa M ^b   Zitman, Frans G ^b   Penninx, Brenda W J H ^a,b,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Alpha amylase; Autonomic nervous system; Determinants; Stress

Indexed keywords

ALPHA AMYLASE SALIVA ISOENZYME; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; ORAL CONTRACEPTIVE AGENT;

ADULT; ALCOHOL CONSUMPTION; ALLERGY; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; CONFOUNDING VARIABLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENDER; HUMAN; LIFESPAN; LUNG DISEASE; MALE; MENTAL DISEASE; MULTIPLE LINEAR REGRESSION ANALYSIS; NETHERLANDS; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ALCOHOL DRINKING; AUTONOMIC NERVOUS SYSTEM; BIOLOGICAL MARKERS; CIRCADIAN RHYTHM; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; SALIVARY ALPHA-AMYLASES; SAMPLE SIZE; SPECIMEN HANDLING; YOUNG ADULT;

EID: 84860181659     PISSN: 01678760     EISSN: 18727697     Source Type: Journal    
DOI: 10.1016/j.ijpsycho.2012.01.005     Document Type: Article

References (54)

1. Aguirre A., Levine M.J., Cohen R.E., Tabak L.A. Immunochemical quantitation of alpha-amylase and secretory IgA in parotid saliva from people of various ages. Archives of Oral Biology 1987, 32:297-301.
2. Ben-Aryeh H., Shalev A., Szargel R., Laor A., Laufer D., Gutman D. The salivary flow rate and composition of whole and parotid resting and stimulated saliva in young and old healthy subjects. Biochemical Medicine and Metabolic Biology 1986, 36:260-265.
3. Bhoola K.D., Matthews R.W., Roberts F. A survey of salivary kallikrein and amylase in a population of schoolgirls, throughout the menstrual cycle. Clinical Science and Molecular Medicine. Supplement 1978, 55:561-566.
4. Bosch J.A., Veerman E.C., de Geus E.J., Proctor G.B. alpha-Amylase as a reliable and convenient measure of sympathetic activity: don't start salivating just yet!. Psychoneuroendocrinology 2011, 36:449-453.
5. Bus B.A., Molendijk M.L., Penninx B.J., Buitelaar J.K., Kenis G., Prickaerts J., Elzinga B.M., Voshaar R.C. Determinants of serum brain-derived neurotrophic factor. Psychoneuroendocrinology 2010, 36:228-239.
6. Carney R.M., Freedland K.E., Veith R.C. Depression, the autonomic nervous system, and coronary heart disease. Psychosomatic Medicine 2005, 67(Suppl 1):S29-S33.
7. Chatterton R.T., Vogelsong K.M., Lu Y.C., Ellman A.B., Hudgens G.A. Salivary alpha-amylase as a measure of endogenous adrenergic activity. Clinical Physiology 1996, 16:433-448.
8. Chatterton R.T., Vogelsong K.M., Lu Y.C., Hudgens G.A. Hormonal responses to psychological stress in men preparing for skydiving. Journal of Clinical Endocrinology and Metabolism 1997, 82:2503-2509.
9. Craig C.L., Marshall A.L., Sjostrom M., Bauman A.E., Booth M.L., Ainsworth B.E., Pratt M., Ekelund U., Yngve A., Sallis J.F., Oja P. International physical activity questionnaire: 12-country reliability and validity. Medicine and Science in Sports and Exercise 2003, 35:1381-1395.
10. DeCaro J.A. Methodological considerations in the use of salivary alpha-amylase as a stress marker in field research. American Journal of Human Biology 2008, 20:617-619.
11. Dutta S.K., Orestes M., Vengulekur S., Kwo P. Ethanol and human saliva: effect of chronic alcoholism on flow rate, composition, and epidermal growth factor. American Journal of Gastroenterology 1992, 87:350-354.
12. Ehlert U., Erni K., Hebisch G., Nater U. Salivary alpha-amylase levels after yohimbine challenge in healthy men. Journal of Clinical Endocrinology and Metabolism 2006, 91:5130-5133.
13. Goi N., Hirai Y., Harada H., Ikari A., Ono T., Kinae N., Hiramatsu M., Nakamura K., Takagi K. Comparison of peroxidase response to mental arithmetic stress in saliva of smokers and non-smokers. The Journal of Toxicological Sciences 2007, 32:121-127.
14. Granger D.A., Blair C., Willoughby M., Kivlighan K.T., Hibel L.C., Fortunato C.K., Wiegand L.E. Individual differences in salivary cortisol and alpha-amylase in mothers and their infants: relation to tobacco smoke exposure. Developmental Psychobiology 2007, 49:692-701.
15. Granger D.A., Kivlighan K.T., el Sheikh M., Gordis E.B., Stroud L.R. Salivary alpha-amylase in biobehavioral research: recent developments and applications. Annals of the New York Academy of Sciences 2007, 1098:122-144.
16. Greabu M., Battino M., Totan A., Mohora M., Mitrea N., Totan C., Spinu T., Didilescu A. Effect of gas phase and particulate phase of cigarette smoke on salivary antioxidants. What can be the role of vitamin C and pyridoxine?. Pharmacological Reports 2007, 59:613-618.
17. Guinjoan S.M., Bernabo J.L., Cardinali D.P. Cardiovascular tests of autonomic function and sympathetic skin responses in patients with major depression. Journal of Neurology, Neurosurgery, and Psychiatry 1995, 59:299-302.
18. Hellhammer J., Fries E., Schweisthal O.W., Schlotz W., Stone A.A., Hagemann D. Several daily measurements are necessary to reliably assess the cortisol rise after awakening: state- and trait components. Psychoneuroendocrinology 2007, 32:80-86.
19. Kurahashi M., Inomata K. Effects of dietary consistency and water content on parotid amylase secretion and gastric starch digestion in rats. Archives of Oral Biology 1999, 44:1013-1019.
20. Laine M., Pienihakkinen K., Ojanotko-Harri A., Tenovuo J. Effects of low-dose oral contraceptives on female whole saliva. Archives of Oral Biology 1991, 36:549-552.
21. Lakatta E.G. Deficient neuroendocrine regulation of the cardiovascular system with advancing age in healthy humans. Circulation 1993, 87:631-636.
22. Lavi S., Nevo O., Thaler I., Rosenfeld R., Dayan L., Hirshoren N., Gepstein L., Jacob G. Effect of aging on the cardiovascular regulatory systems in healthy women. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2007, 292:R788-R793.
23. Lehofer M., Moser M., Hoehn-Saric R., McLeod D., Liebmann P., Drnovsek B., Egner S., Hildebrandt G., Zapotoczky H.G. Major depression and cardiac autonomic control. Biological Psychiatry 1997, 42:914-919.
24. Lorentz K. Approved recommendation on IFCC methods for the measurement of catalytic concentration of enzymes. Part 9. IFCC method for alpha-amylase (1,4-alpha-D-glucan 4-glucanohydrolase, EC 3.2.1.1). International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Committee on Enzymes. Clinical Chemistry and Laboratory Medicine 1998, 36:185-203.
25. Mackie D.A., Pangborn R.M. Mastication and its influence on human salivary flow and alpha-amylase secretion. Physiology and Behavior 1990, 47:593-595.
26. Maier H., Born I.A., Veith S., Adler D., Seitz H.K. The effect of chronic ethanol consumption on salivary gland morphology and function in the rat. Alcoholism, Clinical and Experimental Research 1986, 10:425-427.
27. Monteleone P., Scognamiglio P., Monteleone A.M., Mastromo D., Steardo L., Serino I., Maj M. Abnormal diurnal patterns of salivary alpha-amylase and cortisol secretion in acute patients with anorexia nervosa. The World Journal of Biological Psychiatry 2011, 12:455-461.
28. Nagaya T., Okuno M. No effects of smoking or drinking habits on salivary amylase. Toxicology Letters 1993, 66:257-261.
29. Nagler R., Lischinsky S., Diamond E., Drigues N., Klein I., Reznick A.Z. Effect of cigarette smoke on salivary proteins and enzyme activities. Archives of Biochemistry and Biophysics 2000, 379:229-236.
30. Nater U.M., Rohleder N. Salivary alpha-amylase as a non-invasive biomarker for the sympathetic nervous system: current state of research. Psychoneuroendocrinology 2009, 34:486-496.
31. Nater U.M., La Marca R., Florin L., Moses A., Langhans W., Koller M.M., Ehlert U. Stress-induced changes in human salivary alpha-amylase activity-associations with adrenergic activity. Psychoneuroendocrinology 2005, 31:49-585.
32. Nater U.M., Rohleder N., Gaab J., Berger S., Jud A., Kirschbaum C., Ehlert U. Human salivary alpha-amylase reactivity in a psychosocial stress paradigm. International Journal of Psychophysiology 2005, 55:333-342.
33. Nater U.M., Rohleder N., Schlotz W., Ehlert U., Kirschbaum C. Determinants of the diurnal course of salivary alpha-amylase. Psychoneuroendocrinology 2007, 32:392-401.
34. Nater U.M., Bohus M., Abbruzzese E., Ditzen B., Gaab J., Kleindienst N., Ebner-Priemer U., Mauchnik J., Ehlert U. Increased psychological and attenuated cortisol and alpha-amylase responses to acute psychosocial stress in female patients with borderline personality disorder. Psychoneuroendocrinology 2010, 35:1565-1572.
35. Nederfors T., Dahlof C. Effects on salivary flow rate and composition of withdrawal of and re-exposure to the beta 1-selective antagonist metoprolol in a hypertensive patient population. European Journal of Oral Sciences 1996, 104:262-268.
36. Nederfors T., Dahlof C., Twetman S. Effects of the beta-adrenoceptor antagonists atenolol and propranolol on human unstimulated whole saliva flow rate and protein composition. Scandinavian Journal of Dental Research 1994, 102:235-237.
37. Penninx B.W., Beekman A.T., Smit J.H., Zitman F.G., Nolen W.A., Spinhoven P., Cuijpers P., De Jong P.J., Van Marwijk H.W., Assendelft W.J., Van Der M.K., Verhaak P., Wensing M., de Graaf R., Hoogendijk W.J., Ormel J., van Dyck R. The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. International Journal of Methods in Psychiatric Research 2008, 17:121-140.
38. Perec C.J., Celener D., Tiscornia O.M., Baratti C. Effects of chronic ethanol administration on the autonomic innervation of salivary glands, pancreas and heart. American Journal of Gastroenterology 1979, 72:46-59.
39. Pohjavaara P., Telaranta T., Vaisanen E. The role of the sympathetic nervous system in anxiety: is it possible to relieve anxiety with endoscopic sympathetic block?. Nordic Journal of Psychiatry 2003, 57:55-60.
40. Rantonen P.J., Meurman J.H. Correlations between total protein, lysozyme, immunoglobulins, amylase, and albumin in stimulated whole saliva during daytime. Acta Odontologica Scandinavica 2000, 58:160-165.
41. Rohleder N., Nater U.M. Determinants of salivary alpha-amylase in humans and methodological considerations. Psychoneuroendocrinology 2009, 34:469-485.
42. Rohleder N., Nater U.M., Wolf J.M., Ehlert U., Kirschbaum C. Psychosocial stress-induced activation of salivary alpha-amylase: an indicator of sympathetic activity?. Annals of the New York Academy of Sciences 2004, 1032:258-263.
43. Rohleder N., Wolf J.M., Maldonado E.F., Kirschbaum C. The psychosocial stress-induced increase in salivary alpha-amylase is independent of saliva flow rate. Psychophysiology 2006, 43:645-652.
44. Salvolini E., Mazzanti L., Martarelli D., Di G.R., Fratto G., Curatola G. Changes in the composition of human unstimulated whole saliva with age. Aging (Milano) 1999, 11:119-122.
45. Scannapieco F.A., Torres G., Levine M.J. Salivary alpha-amylase: role in dental plaque and caries formation. Critical Reviews in Oral Biology and Medicine 1993, 4:301-307.
46. Strahler J., Berndt C., Kirschbaum C., Rohleder N. Aging diurnal rhythms and chronic stress: distinct alteration of diurnal rhythmicity of salivary alpha-amylase and cortisol. Biological Psychology 2010, 84:248-256.
47. Tenovuo J., Laine M., Soderling E., Irjala K. Evaluation of salivary markers during the menstrual cycle: peroxidase, protein, and electrolytes. Biochemical Medicine 1981, 25:337-345.
48. Thoma, M.V., Joksimovic, L., Kirschbaum, C., Wolf, J.M., Rohleder, N., in press. Altered salivary alpha-amylase awakening response in Bosnian War refugees with posttraumatic stress disorder. Psychoneuroendocrinology.
49. van Stegeren A., Rohleder N., Everaerd W., Wolf O.T. Salivary alpha amylase as marker for adrenergic activity during stress: effect of betablockade. Psychoneuroendocrinology 2005, 31:137-141.
50. van Veen J.F., van Vliet I.M., DeRijk R.H., van Pelt J., Mertens B., Zitman F.G. Elevated alpha-amylase but not cortisol in generalized social anxiety disorder. Psychoneuroendocrinology 2008, 31:137-141.
51. Veith R.C., Lewis N., Linares O.A., Barnes R.F., Raskind M.A., Villacres E.C., Murburg M.M., Ashleigh E.A., Castillo S., Peskind E.R. Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Archives of General Psychiatry 1994, 51:411-422.
52. Vreeburg S.A., Kruijtzer B.P., van Pelt J., van Dyck R., DeRijk R.H., Hoogendijk W.J., Smit J.H., Zitman F.G., Penninx B.W. Associations between sociodemographic, sampling and health factors and various salivary cortisol indicators in a large sample without psychopathology. Psychoneuroendocrinology 2009, 34:1109-1120.
53. World Health Organization Collaboration Centre for Drugs Statistics Methodology, 2008. Anatomical Therapeutic Chemical (ATC) Classification System. Available at: http://www.whocc.no/atcddd.
54. Zappacosta B., Persichilli S., Mordente A., Minucci A., Lazzaro D., Meucci E., Giardina B. Inhibition of salivary enzymes by cigarette smoke and the protective role of glutathione. Human and Experimental Toxicology 2002, 21:7-11.